Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery

NCT01537107 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Acinar Cell Adenocarcinoma of the Pancreas
Duct Cell Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Stage IV Pancreatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: vismodegib
DRUG: sirolimus
PROCEDURE: positron emission tomography
PROCEDURE: computed tomography
OTHER: pharmacological study
OTHER: laboratory biomarker analysis
RADIATION: fludeoxyglucose F 18

Sponsor

Mayo Clinic